Seattle, WA, United States of America

Thomas A Baillie



 

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Inventor Thomas A. Baillie**

Introduction

Thomas A. Baillie is a notable inventor based in Seattle, WA, known for his impactful contributions in the field of biomedicine. With a total of three patents to his name, Baillie's innovations focus on delivering active agents through biodegradable lipids, paving the way for advancements in therapeutic applications.

Latest Patents

Among Baillie's significant inventions is his patent for biodegradable lipids designed for the delivery of active agents. This invention involves the development of cationic lipids that incorporate biodegradable groups situated within the lipidic moiety, which enhances their functionality in nucleic acid delivery systems. These cationic lipids can be encapsulated in lipid particles that also contain a neutral lipid, a lipid that reduces aggregation, and optionally, a sterol. This innovative approach ultimately aims to improve the efficacy of therapeutic agents, such as nucleic acids, in reaching their targets.

Career Highlights

Currently, Thomas A. Baillie is associated with Alnylam Pharmaceuticals, Inc., a leading company dedicated to the development of RNA interference (RNAi) therapies. His work at Alnylam Pharmaceuticals is pivotal, as it aligns with the company's mission to revolutionize the treatment of various diseases through innovative drug delivery mechanisms and novel therapeutic solutions.

Collaborations

Throughout his career, Baillie has collaborated with esteemed colleagues in his field, including Muthiah Manoharan and Martin A. Maier. These collaborations have undoubtedly enriched his research and have contributed to the successful development of his patented innovations.

Conclusion

Thomas A. Baillie's inventive spirit and dedication to advancing biomedical technologies showcase the vital role of inventors in shaping modern therapeutics. His ongoing work at Alnylam Pharmaceuticals, along with his innovative patented technologies, continues to influence the landscape of drug delivery systems and highlights his commitment to enhancing patient outcomes through science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…